首页> 外文期刊>Journal of neuro-oncology. >Reducing the overall treatment time for radiotherapy of metastatic spinal cord compression (MSCC): 3-year results of a prospective observational multi-center study.
【24h】

Reducing the overall treatment time for radiotherapy of metastatic spinal cord compression (MSCC): 3-year results of a prospective observational multi-center study.

机译:减少转移性脊髓压迫(MSCC)放射治疗的总治疗时间:一项前瞻性观察性多中心研究的3年结果。

获取原文
获取原文并翻译 | 示例
           

摘要

BACKGROUND: This prospective multi-center study investigates a reduction of the overall treatment time for radiotherapy of MSCC, which is important for these mostly disabled patients. PATIENTS AND METHODS: Two standard fractionation schedules, 30 Gy/10 fractions/2 weeks (n = 71) and 40 Gy/20 fractions/4 weeks (n = 65) were compared for functional outcome and ambulatory status. Motor function was graded using an 8-point-scale before RT, at the end and at 6, 12 and 24 weeks after RT. A multi-variate analysis was performed for functional outcome. Included variables were the fractionation schedule and the three relevant prognostic factors. These factors are the type of primary tumor, the time of developing motor deficits before RT and the pre-treatment ambulatory status. RESULTS: The ambulatory rates were 49% in the 30 Gy group and 52% in the 40 Gy group before RT (P = 0.888), and 56% and 60% after RT (P = 0.888). Improvement of motor function occurred in 45% of the 30 Gy group and 40% of the 40 Gy group (P = 0.752). The relevant prognostic factors were comparably distributed in both groups. According to the multivariate analysis, a slower development of motor deficits (P < 0.001), a favorable histology (P = 0.040) and being ambulatory (P = 0.045) were associated with better functional outcome, whereas the fractionation schedule had no significant impact (P = 0.311). CONCLUSIONS: The data suggest both schedules to be comparably effective for functional outcome. Thus, 30 Gy/10 fractions/2 weeks should be applied instead of 40 Gy/20 fractions/4 weeks. The reduction of the overall treatment time from 4 to 2 weeks means less discomfort for the paraparetic or paraplegic patient.
机译:背景:这项前瞻性多中心研究探讨了减少MSCC放射治疗的总体治疗时间,这对于这些大多数残疾患者而言很重要。患者和方法:比较了两种标准的分馏方案,即功能预后和非卧床状态,分别为30 Gy / 10分数/ 2周(n = 71)和40 Gy / 20分数/ 4周(n = 65)。运动功能在放疗前,放疗结束后,放疗后6、12和24周使用8分制进行评分。对功能结局进行了多变量分析。所包括的变量是分级计划和三个相关的预后因素。这些因素是原发肿瘤的类型,放疗前发展运动功能障碍的时间以及治疗前的卧床状态。结果:30 Gy组的门诊率分别为:RT前为30 Gy组的49%,40 Gy组为52%(P = 0.888),RT后为56%和60%(P = 0.888)。 30 Gy组的45%和40 Gy组的40%发生了运动功能改善(P = 0.752)。相关的预后因素在两组中均相当。根据多变量分析,运动功能障碍的发展较慢(P <0.001),组织学良好(P = 0.040)和能行走的(P = 0.045)与较好的功能结局相关,而分馏时间表没有明显影响( P = 0.311)。结论:数据表明两个时间表对于功能结局均具有相当的效果。因此,应该应用30 Gy / 10分数/ 2周而不是40 Gy / 20分数/ 4周。总体治疗时间从4周减少到2周,意味着轻瘫或截瘫患者的不适感降低。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号